(Q33821481)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

review article

1 reference

title

Making Meaningful Clinical Use of Biomarkers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

0 references

Matthew J Selleck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Maheswari Senthil

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

publication date

19 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

1177271917715236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

Clinically Meaningful Use of Blood Tumor Markers in Oncology.

24 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Predicting the Future - Big Data, Machine Learning, and Clinical Medicine

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Predicting Clinical Outcomes Using Molecular Biomarkers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Systemic Chemotherapy in Advanced Pancreatic Cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Adjuvant chemotherapy for rectal cancer: Is it needed?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Survivin is released from cancer cells via exosomes.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Use of archived specimens in evaluation of prognostic and predictive biomarkers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Targeted proteomic strategy for clinical biomarker discovery

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

The clinical utility of the CA 19-9 tumor-associated antigen.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5479428

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

4 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F1177271917715236

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1177271917715236

Multiple myeloma: how did it begin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1177271917715236

Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1177271917715236

Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1177271917715236

Serum proteomics profiling—a young technology begins to mature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1177271917715236

Procalcitonin increase in early identification of critically ill patients at high risk of mortality

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28659713

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sequential carcinoembryonic antigen levels. A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28659713

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28659713

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/1177271917715236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28659713%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference